Bioscience Inc Harvard serves as Executive at Harvard Apparatus Regenerative Technology, Inc., where they oversee executive responsibilities. Since joining the company, Bioscience Inc Harvard has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 1, 2013 involved transacting 8,000,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 1, 2013 | HART | $0 | Other | 8,000,000 | $N/A | Discretionary |
Bioscience Inc Harvard currently holds 0 shares of Harvard Apparatus Regenerative Technology, Inc. (HART), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bioscience Inc Harvard has been a net neutral trader of HART stock. They have purchased $0 and sold $0 worth of shares.
Bioscience Inc Harvard's most recent insider trade was on Nov 1, 2013, when they sold 8,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted